Global Infection Surveillance Solutions Market was valued at US$ 409.9 Million in 2019 and is Expected to Grow at a CAGR of 13.9% Between 2020 and 2027 to Reach US$ 1,177.7 Million by 2027

Infection Surveillance Solutions Market

Infection monitoring software assists healthcare facilities, such as hospitals and others, in reporting data about patients to state and federal authorities. This programme notifies hospital Internet Protocol (IP) addresses in the event of an infection, allowing HAI specialists and nurses to treat infected patients and prevent infection epidemics. The global Infection Surveillance Solutions Market is expected to be worth US$ 1,177.7 million by the end of 2027. The global market for infection surveillance solutions is projected to be hampered by a lack of suitable data management and processing resources. Inadequate and erroneous data regarding a patient's medical history and care results in inappropriate inferences in surveillance systems due to poor data management.

Over the projected period, the Global Infection Surveillance Solutions Market is expected to rise due to the high prevalence of hospital-acquired infections (HAIs). The incidence of healthcare associated infections among adult inpatients at nineteen big Australian acute-care public hospitals: a point prevalence survey, for example, was 9.9% according to a study published in BMC Antimicrobial Resistance & Infection Control in July 2019. Prevalence rates in hospitals ranged from 5.7 percent to 17.0 percent. Furthermore, the worldwide infection surveillance solutions market is likely to benefit from an increase in the number of emergency surgeries. For example, according to the Australian Institute of Health and Welfare's Hospitals at a Glance 2017–18 report, which was revised in August 2019, emergency surgery admissions climbed by 12% between 2016 and 2017.

The introduction of quick tests for infection control and surveillance studies is predicted to boost the global Infection Surveillance Solutions Market. OpGen, Inc., a precision medicine business, for example, launched a new Research Use Only fast test for infection control and surveillance studies in February 2018. Furthermore, the introduction of low-cost COVID-19 testing and surveillance systems is projected to boost the global infection surveillance solutions market's growth. Stanford University, the Chan Zuckerberg Biohub, and a group of collaborators, for example, established a low-cost system to collect samples for COVID-19 testing and monitor populations for the disease in September 2020.